WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$1.82B$32.04-1.90%$237.47M13.63x0.64
CORT
CORCEPT THERAPEUTICS INC
NASDAQ
Biotechnology
$3.53B$33.881.77%$122.89M29.46x0.20
HALO
HALOZYME THERAPEUTICS INC
NASDAQ
Biotechnology
$6.88B$54.04-0.48%$495.45M22.06x9.36
CPRX
CATALYST PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.00B$16.941.32%$122.26M28.23x0.15
EXEL
EXELIXIS INC
NASDAQ
Biotechnology
$6.58B$22.600.18%$312.76M35.31x0.32
UTHR
UNITED THERAPEUTICS CORP
NASDAQ
Biotechnology
$14.60B$329.160.15%$1.49B14.72x0.22
MDXG
MIMEDX GROUP INC
NASDAQ
Biotechnology
$1.06B$7.16-1.78%$50.76M13.77x0.42
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
NASDAQ
Biotechnology
$1.51B$21.230.33%-$16.36M176.92x0.20
NVO
NOVO NORDISK A S
NYSE
Biotechnology
$593.25B$131.541.19%$17.67B45.78x2.02
INCY
INCYTE CORP
NASDAQ
Biotechnology
$14.79B$65.870.76%$1.11B19.78x0.32
FENC
FENNEC PHARMACEUTICALS INC
NASDAQ
Biotechnology
$174.59M$6.390.79%$8.10M71.00x21.96
REGN
REGENERON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$117.19B$1,063.60-0.34%$4.55B29.45x0.27
TGTX
TG THERAPEUTICS INC
NASDAQ
Biotechnology
$3.25B$21.00-1.08%$53.85M72.41x1.33
SRPT
SAREPTA THERAPEUTICS INC
NASDAQ
Biotechnology
$13.76B$145.611.27%$91.13M355.15x2.36
ROIV
ROIVANT SCIENCES LTD
NASDAQ
Biotechnology
$8.13B$11.00-0.99%$4.43B1.98x0.13
RPRX
ROYALTY PHARMA PLC
NASDAQ
Biotechnology
$16.81B$28.14-0.67%$983.33M15.72x0.64
BMRN
BIOMARIN PHARMACEUTICAL INC
NASDAQ
Biotechnology
$15.97B$84.090.90%$359.85M77.15x0.36
PBYI
PUMA BIOTECHNOLOGY INC
NASDAQ
Biotechnology
$176.55M$3.66-1.08%$41.45M11.09x3.20
PTGX
PROTAGONIST THERAPEUTICS INC
NASDAQ
Biotechnology
$2.09B$35.55-0.45%$168.74M13.31x0.12
GMAB
GENMAB A
NASDAQ
Biotechnology
$18.35B$27.751.87%N/A23.11x0.13
MEIP
MEI PHARMA INC
NASDAQ
Biotechnology
$19.06M$2.860.00%$28.01M0.73x0.40
LGND
LIGAND PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.79B$99.760.81%$158.80M18.30x0.13
VRTX
VERTEX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$126.85B$491.570.71%$5.01B31.55x0.29
KRYS
KRYSTAL BIOTECH INC
NASDAQ
Biotechnology
$5.82B$203.661.41%$65.04M102.86x0.07
OCUP
OCUPHIRE PHARMA INC
NASDAQ
Biotechnology
$51.59M$1.992.58%-$11.28M-4.15x0.13
ORMP
ORAMED PHARMACEUTICALS INC
NASDAQ
Biotechnology
$103.60M$2.551.19%$9.81M9.81x0.23
SPRO
SPERO THERAPEUTICS INC
NASDAQ
Biotechnology
$75.58M$1.40-1.41%$26.26M3.18x0.74
BNOX
BIONOMICS LIMITED
NASDAQ
Biotechnology
$9.71M$0.841.33%N/A0.03x0.34
GNFT
GENFIT SA
NASDAQ
Biotechnology
$207.31M$4.16-10.34%-$23.09M-6.60x1.56
TECH
BIO-TECHNE CORP
NASDAQ
Biotechnology
$11.89B$75.46-0.61%$354.14M59.42x0.35
VYNE
VYNE THERAPEUTICS INC
NASDAQ
Biotechnology
$30.95M$2.13-0.93%-$29.08M-1.76x0.10
PHAR
PHARMING GROUP NV
NASDAQ
Biotechnology
$571.08M$8.51-2.96%$8.15M-49.48x1.15
CRSP
CRISPR THERAPEUTICS AG
NASDAQ
Biotechnology
$4.63B$54.56-2.94%-$195.23M-20.28x0.17
LPCN
LIPOCINE INC
NASDAQ
Biotechnology
$30.22M$5.651.99%-$8.94M-3.32x0.06
TECX
TECTONIC THERAPEUTIC INC
NASDAQ
Biotechnology
$61.73M$16.500.86%$30.44M1.96x0.04
PLX
PROTALIX BIOTHERAPEUTICS INC
NYSEMKT
Biotechnology
$80.65M$1.100.92%$9.65M11.00x2.02
MIRM
MIRUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.86B$39.495.67%-$127.08M-10.47x1.78
TRDA
ENTRADA THERAPEUTICS INC
NASDAQ
Biotechnology
$573.23M$16.980.59%$43.74M24.26x0.90
TARS
TARSUS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.02B$27.04-0.77%-$143.00M-5.72x0.27
BGNE
BEIGENE LTD
NASDAQ
Biotechnology
$16.20B$154.741.78%-$713.52M-266.79x0.69
JAZZ
JAZZ PHARMACEUTICALS PLC
NASDAQ
Biotechnology
$6.87B$109.010.16%$1.16B20.84x2.06
TFFP
TFF PHARMACEUTICALS INC
NASDAQ
Biotechnology
$5.86M$1.892.16%-$19.41M-0.19x0.73
LEGN
LEGEND BIOTECH CORP
NASDAQ
Biotechnology
$10.69B$58.740.86%N/A-22.77x0.53
OCUL
OCULAR THERAPEUTIX INC
NASDAQ
Biotechnology
$1.22B$7.851.29%-$98.23M-7.07x0.32
RNA
AVIDITY BIOSCIENCES INC
NASDAQ
Biotechnology
$4.32B$45.120.78%-$223.21M-15.24x0.15
PRTA
PROTHENA CORP PUBLIC LTD CO
NASDAQ
Biotechnology
$1.27B$23.58-0.13%-$177.60M-7.32x0.24
VTGN
VISTAGEN THERAPEUTICS INC
NASDAQ
Biotechnology
$98.91M$3.66-1.08%-$28.79M-2.41x0.08
SGMT
SAGIMET BIOSCIENCES INC
NASDAQ
Biotechnology
$98.61M$3.09-4.04%-$27.78M-0.08x0.02
FULC
FULCRUM THERAPEUTICS INC
NASDAQ
Biotechnology
$497.23M$8.00-1.48%-$97.34M-5.00x0.09
JANX
JANUX THERAPEUTICS INC
NASDAQ
Biotechnology
$2.32B$44.683.79%-$53.56M-36.93x0.05
ZLAB
ZAI LAB LTD
NASDAQ
Biotechnology
$1.85B$18.66-0.74%-$321.14M-5.33x0.30
QSI
QUANTUM-SI INC
NASDAQ
Biotechnology
$146.07M$1.03-5.50%-$85.96M-1.58x0.09
PRAX
PRAXIS PRECISION MEDICINES INC
NASDAQ
Biotechnology
$940.25M$54.961.65%-$124.08M-3.72x0.09
AUPH
AURINIA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$795.19M$5.56-0.18%-$41.87M-13.24x0.44
BRTX
BIORESTORATIVE THERAPIES INC
NASDAQ
Biotechnology
$11.17M$1.65-1.20%-$6.67M-1.21x0.24
ACIU
AC IMMUNE SA
NASDAQ
Biotechnology
$345.21M$3.48-4.13%-$57.43M-5.19x0.16
VRDN
VIRIDIAN THERAPEUTICS INC
NASDAQ
Biotechnology
$923.51M$14.470.00%-$215.27M-3.22x0.08
AGIO
AGIOS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.65B$46.61-2.24%-$335.52M-7.38x0.14
IMMP
IMMUTEP LTD
NASDAQ
Biotechnology
$230.63M$1.940.00%N/A-7.61x0.07
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
NASDAQ
Biotechnology
$55.70M$4.86-1.96%-$6.89M-7.37x0.24
XBIO
XENETIC BIOSCIENCES INC
NASDAQ
Biotechnology
$6.41M$4.161.22%-$4.47M-1.42x0.08
CALT
CALLIDITAS THERAPEUTICS AB
NASDAQ
Biotechnology
$1.16B$38.790.44%-$31.50M-24.29x4.55
ATYR
ATYR PHARMA INC
NASDAQ
Biotechnology
$113.18M$1.640.00%-$51.17M-1.82x0.34
INO
INOVIO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$260.92M$10.07-2.99%-$120.74M-1.84x0.37
MNKD
MANNKIND CORP
NASDAQ
Biotechnology
$1.55B$5.71-0.17%$45.65M142.75x-3.09
KPRX
KIORA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$13.13M$4.509.76%$2.95M-0.45x0.22
VNDA
VANDA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$355.59M$6.110.66%$711.00k-67.89x0.20
DNTH
DIANTHUS THERAPEUTICS INC
NASDAQ
Biotechnology
$779.52M$26.560.08%-$43.10M6.93x0.03
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$4.77M$3.54-6.84%-$5.18M-0.95x0.04
IMCR
IMMUNOCORE HOLDINGS PLC
NASDAQ
Biotechnology
$1.99B$39.782.34%-$51.58M-33.29x1.77
KZR
KEZAR LIFE SCIENCES INC
NASDAQ
Biotechnology
$45.86M$0.63-2.02%-$98.68M-0.45x0.18
ADAG
ADAGENE INC
NASDAQ
Biotechnology
$110.73M$2.51-2.33%-$14.94M-5.74x0.64
ARGX
ARGENX SE
NASDAQ
Biotechnology
$27.90B$471.321.02%-$209.00M-84.03x0.11
QURE
UNIQURE NV
NASDAQ
Biotechnology
$375.77M$7.74-0.77%-$226.99M-1.25x4.25
IVVD
INVIVYD INC
NASDAQ
Biotechnology
$137.21M$1.15-5.74%-$204.77M-0.61x0.21
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$640.71M$23.791.58%-$116.03M-5.90x0.59
AUTL
AUTOLUS THERAPEUTICS PLC
NASDAQ
Biotechnology
$1.13B$4.25-2.30%-$146.22M-3.51x0.55
ACAD
ACADIA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$2.93B$17.75-1.39%$25.56M-1,775.00x0.84
DBVT
DBV TECHNOLOGIES SA
NASDAQ
Biotechnology
$81.00M$0.841.20%-$93.17M-1.02x0.31
GERN
GERON CORP
NASDAQ
Biotechnology
$2.73B$4.60-1.50%-$190.52M-13.14x0.40
ALT
ALTIMMUNE INC
NASDAQ
Biotechnology
$445.27M$6.28-4.12%-$91.79M-3.90x0.09
ADMA
ADMA BIOLOGICS INC
NASDAQ
Biotechnology
$3.10B$13.362.38%$28.04M-668.00x1.28
ARDX
ARDELYX INC
NASDAQ
Biotechnology
$1.29B$5.510.36%-$53.48M-19.00x1.27
SPRY
ARS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.02B$10.540.91%-$49.63M-20.27x0.02
BRNS
BARINTHUS BIOTHERAPEUTICS PLC
NASDAQ
Biotechnology
$54.65M$1.40-2.71%-$66.23M-0.76x0.16
CTMX
CYTOMX THERAPEUTICS INC
NASDAQ
Biotechnology
$107.53M$1.381.47%$26.34M6.90x-6.83
IDYA
IDEAYA BIOSCIENCES INC
NASDAQ
Biotechnology
$3.09B$40.89-0.54%-$124.76M-20.34x0.03
ZVRA
ZEVRA THERAPEUTICS INC
NASDAQ
Biotechnology
$253.21M$6.05-5.02%-$46.33M-4.48x2.10
VALN
VALNEVA SE
NASDAQ
Biotechnology
$518.21M$7.46-2.98%N/A-19.28x1.66
LEXX
LEXARIA BIOSCIENCE CORP
NASDAQ
Biotechnology
$43.16M$2.73-1.09%-$4.63M-6.20x0.03
ZYME
ZYMEWORKS INC
NASDAQ
Biotechnology
$691.49M$9.78-0.31%-$111.14M-5.49x0.26
FATE
FATE THERAPEUTICS INC
NASDAQ
Biotechnology
$486.06M$4.27-0.93%-$171.14M-2.22x0.34
GLYC
GLYCOMIMETICS INC
NASDAQ
Biotechnology
$18.31M$0.28-4.05%-$36.35M-0.49x0.18
LQDA
LIQUIDIA CORP
NASDAQ
Biotechnology
$846.32M$11.080.82%-$97.50M-7.10x1.29
SEER
SEER INC
NASDAQ
Biotechnology
$116.89M$1.800.00%-$76.99M-1.38x0.10
PGEN
PRECIGEN INC
NASDAQ
Biotechnology
$401.35M$1.59-4.22%-$90.64M-4.08x0.39
XOMA
XOMA CORP
NASDAQ
Biotechnology
$326.58M$28.062.37%-$34.73M-7.16x1.67
CCCC
C4 THERAPEUTICS INC
NASDAQ
Biotechnology
$414.90M$6.03-3.52%-$116.02M-2.54x0.54
CRNX
CRINETICS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$4.15B$52.660.48%-$232.29M-14.01x0.12
ZNTL
ZENTALIS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$262.75M$3.70-6.33%-$218.17M-1.11x0.22

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jul 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the top biotech stock with a Zen Score of 72, which is 49 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -9.9% over the past year, overperforming other biotech stocks by 6 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $47.25, an upside of 47.47% from Harmony Biosciences Holdings's current stock price of $32.04.

Harmony Biosciences Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Harmony Biosciences Holdings, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the second best biotech stock with a Zen Score of 69, which is 46 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 46.86% over the past year, overperforming other biotech stocks by 63 percentage points.

Corcept Therapeutics has an average 1 year price target of $46.67, an upside of 37.74% from Corcept Therapeutics's current stock price of $33.88.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Halozyme Therapeutics (NASDAQ:HALO)


Halozyme Therapeutics (NASDAQ:HALO) is the third best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 22 out of 33 due diligence checks and has strong fundamentals. Halozyme Therapeutics has seen its stock return 28.7% over the past year, overperforming other biotech stocks by 45 percentage points.

Halozyme Therapeutics has an average 1 year price target of $59.83, an upside of 10.72% from Halozyme Therapeutics's current stock price of $54.04.

Halozyme Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Halozyme Therapeutics, 33.33% have issued a Strong Buy rating, 50% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 2 biotech stocks that have issued dividends in the past year, the 2 biotech stocks with the highest dividend yields are:

1. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.04%, which is the same as the biotech industry average of 0.72%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

2. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.42%, which is the same as the biotech industry average of 0.72%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 25.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.08% in the last day, and down -1.77% over the last week. Silo Pharma was the among the top losers in the biotechnology industry, dropping -29.11% yesterday.

Silo Pharma shares are trading lower after the company announced a $2.1 million registered direct offering of 763,638 million shares of its Common Stock at $2.75 per share.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 86 points higher than the biotech industry average of 14. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -9.4% in the past year. It has overperformed other stocks in the biotech industry by 6 percentage points.

2. Gri Bio (NASDAQ:GRI)


Gri Bio (NASDAQ:GRI) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Gri Bio has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Gri Bio's stock has dropped -99.53% in the past year. It has underperformed other stocks in the biotech industry by -84 percentage points.

3. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Exelixis has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Exelixis's stock has gained 15.66% in the past year. It has overperformed other stocks in the biotech industry by 32 percentage points.

Are biotech stocks a good buy now?

54.3% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 76.34% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -18.27x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.